Protalix Biotherapeutics (PLX)
NYSE MKT:PLX
Holding PLX?
Track your performance easily

Protalix (PLX) Financial Statements

741 Followers

Protalix Financial Overview

Protalix's market cap is currently ―. The company's EPS TTM is $-0.219; its P/E ratio is -5.94; Protalix is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 13.47M$ 3.75M$ 10.49M$ 10.35M$ 35.08M
Gross Profit$ 4.02M$ 1.15M$ 1.63M$ 5.45M$ 35.08M
EBIT$ -2.27M$ -4.73M$ -5.65M$ -1.72M$ 19.65M
EBITDA$ -1.95M$ -4.41M$ -5.34M$ -1.35M-
Net Income Common Stockholders$ -2.20M$ -4.59M$ -6.04M$ -1.85M$ 19.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.40M$ 27.21M$ 23.63M$ 20.41M$ 48.18M
Total Assets$ 91.54M$ 89.83M$ 84.43M$ 87.57M$ 88.42M
Total Debt$ 26.15M$ 26.37M$ 26.28M$ 26.01M$ 25.97M
Net Debt$ 2.75M$ -837.00K$ 2.65M$ 5.60M$ -22.21M
Total Liabilities$ 62.96M$ 60.04M$ 50.87M$ 49.32M$ 49.42M
Stockholders Equity$ 28.58M$ 29.79M$ 33.57M$ 38.25M$ 39.00M
Cash Flow-
Free Cash Flow$ -3.78M$ 3.59M$ 3.35M$ -7.33M-
Operating Cash Flow$ -3.61M$ 4.19M$ 3.60M$ -6.89M-
Investing Cash Flow$ -180.00K$ -606.00K$ -342.00K$ -20.88M-
Financing Cash Flow-----
Currency in USD

Protalix Earnings and Revenue History

Protalix Debt to Assets

Protalix Cash Flow

Protalix Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis